최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0780725 (2010-05-14) |
등록번호 | US-8571625 (2013-10-29) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 6 인용 특허 : 475 |
The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
1. A method for processing sensor data, comprising: receiving sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration in a host;receiving reference data from a reference glucose monitor, wherein the reference data is indicative of a glucose conc
1. A method for processing sensor data, comprising: receiving sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration in a host;receiving reference data from a reference glucose monitor, wherein the reference data is indicative of a glucose concentration in the host;determining, using a processor module, a conversion function based on the sensor data and the reference data, wherein the conversion function comprises a sensitivity value and a baseline value;validating the conversion function based on predetermined calibration information, wherein the predetermined calibration information comprises sensitivity information and baseline information derived from in vivo testing of at least one other continuous glucose sensor or in vitro testing; andadjusting the conversion function in response to the validation failing a criterion, wherein the adjusting is without reference data obtained from an in vitro self-monitoring blood glucose test after implantation in vivo. 2. The method of claim 1, wherein the sensitivity information is derived from in vitro testing. 3. The method of claim 1, wherein the sensitivity information is derived from in vivo testing of at least one other continuous glucose sensor. 4. The method of claim 1, wherein the sensitivity information is derived from in vitro and in vivo testing of at least one other continuous glucose sensor. 5. The method of claim 1, further comprising converting the sensor data using the conversion function in response to the validation meeting a criterion. 6. The method of claim 1, wherein adjusting the conversion function comprises adjusting the baseline value. 7. The method of claim 6, wherein adjusting the baseline value is based on the predetermined baseline information. 8. The method of claim 1, wherein the predetermined baseline information comprises a range of acceptable baseline values derived from in vivo testing of at least one other continuous glucose sensor. 9. The method of claim 1, wherein adjusting the conversion function comprises adjusting the sensitivity value. 10. The method of claim 9, wherein adjusting the sensitivity value is based on the predetermined sensitivity information. 11. The method of claim 1, further comprising detecting the predetermined calibration information from a calibration code associated with the continuous glucose sensor. 12. The method of claim 11, wherein the calibration code is provided on a housing that supports the continuous glucose sensor. 13. A system for processing sensor data, comprising: a continuous glucose sensor configured to provide sensor data indicative of a glucose concentration in a host; anda processor module configured to determine a conversion function based on the sensor data and substantially time-corresponding reference data from a reference glucose monitor, wherein the conversion function comprises a sensitivity value and a baseline value,validate the conversion function based on predetermined calibration information, wherein the predetermined calibration information comprises sensitivity information and baseline information derived from in vivo testing of at least one other continuous glucose sensor or in vitro testing, andadjust the conversion function in response to the validation failing a criterion, wherein the adjusting is without reference data obtained from an in vitro self-monitoring blood glucose test after implantation in vivo. 14. The system of claim 13, wherein the sensitivity information is derived from in vitro testing. 15. The system of claim 13, wherein the sensitivity information is derived from in vivo testing of at least one other continuous glucose sensor. 16. The system of claim 13, wherein the sensitivity information is derived from in vitro testing and in vivo testing of at least one other continuous glucose sensor. 17. The system of claim 13, wherein the processor module is further configured to convert the sensor data using the conversion function in response to the validation meeting a criterion. 18. The system of claim 13, wherein the processor module is configured to adjust the conversion function by adjusting the baseline value. 19. The system of claim 18, wherein the processor module is configured to adjust the baseline value based on the predetermined baseline information. 20. The system of claim 13, wherein the predetermined baseline information comprises a range of acceptable baseline values derived from in vivo testing of at least one other continuous glucose sensor. 21. The system of claim 13, further comprising: a transmitter unit operably coupled to the glucose sensor, the transmitter unit having a radio frequency transmitter configured to wirelessly transmit sensor data; anda receiver unit comprising a radio frequency receiver and a display, the radio frequency receiver configured to receive the transmitted sensor data and the display configured to display information based on the transmitted sensor data. 22. The system of claim 21, wherein the processor module is incorporated in the transmitter unit, wherein the processor module is configured to convert the sensor data by applying the conversion function to the sensor data prior to the sensor data being transmitted by the radio frequency transmitter. 23. The system of claim 13, wherein the processor module is configured to adjust the conversion function by adjusting the sensitivity value. 24. The system of claim 23, wherein the processor module is configured to adjust the sensitivity value based on the predetermined sensitivity information. 25. The system of claim 13, wherein the processor module is further configured to detect the predetermined calibration information from a calibration code associated with the continuous glucose sensor. 26. The system of claim 25, wherein the calibration code is provided on a housing that supports the continuous glucose sensor. 27. A system for processing sensor data, comprising: a continuous glucose sensor configured to provide sensor data indicative of a glucose concentration in a host; anda processor module configured to determine a conversion function based on the sensor data and substantially time-corresponding reference data from a reference glucose monitor, wherein the conversion function comprises a sensitivity value and a baseline value, and wherein the processor module is configured to validate the conversion function based on predetermined calibration information, wherein the predetermined calibration information comprises sensitivity information and predetermined baseline information, and wherein the processor module is configured to adjust the conversion function in response to the validation failing a criterion, wherein the adjusting is without reference data obtained from an in vitro self-monitoring blood glucose test after implantation in vivo. 28. The system of claim 27, wherein the predetermined calibration information is derived from in vivo testing of at least one other continuous glucose sensor or in vitro testing.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.